William Cruz‐Muñoz
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
- Oncology 13
- Cancer Cells and Metastasis 5
-
- Cancer, Hypoxia, and Metabolism 4
- Protease and Inhibitor Mechanisms 3
- Co-authors
- Robert S. Kerbel (18 shared papers)John M.L. Ebos (2 shared papers)Christina R. Lee (2 shared papers)Georg Arnold Bjarnason (1 shared paper)James G. Christensen (1 shared paper)Shan Man (10 shared papers)Rama Khokha (4 shared papers)Giulio Francia (4 shared papers)
- Journals
- EMBO Molecular Medicine (3 papers)Cancer Research (2 papers)Small (2 papers)Molecular Cancer Therapeutics (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- CanadaUnited StatesThailand
In The Last Decade
William Cruz‐Muñoz
23 papers receiving 2.6k citations
William Cruz‐Muñoz's Hit Papers
Peers
Comparison fields: 5 of 91
- Cancer Research 914
- Oncology 1.0k
- Immunology and Allergy 126
- Biotechnology 178
- Hepatology 148
Countries citing papers authored by William Cruz‐Muñoz
This map shows the geographic impact of William Cruz‐Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Cruz‐Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Cruz‐Muñoz more than expected).
Fields of papers citing papers by William Cruz‐Muñoz
This network shows the impact of papers produced by William Cruz‐Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Cruz‐Muñoz. The network helps show where William Cruz‐Muñoz may publish in the future.
Co-authors
The 25 scholars most cited alongside William Cruz‐Muñoz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis Hit paper breakdown → | 2009 | 1489 |
| 2 | 2011 | 314 | |
| 3 | 2008 | 113 | |
| 4 | 2008 | 110 | |
| 5 | 2010 | 94 | |
| 6 | 2014 | 66 | |
| 7 | 2012 | 50 | |
| 8 | 2005 | 49 | |
| 9 | 2006 | 49 | |
| 10 | 2010 | 45 | |
| 11 | 2022 | 45 | |
| 12 | 2007 | 41 | |
| 13 | 2021 | 38 | |
| 14 | 2014 | 37 | |
| 15 | 2020 | 30 | |
| 16 | 2009 | 29 | |
| 17 | 2020 | 24 | |
| 18 | 2013 | 19 | |
| 19 | 2014 | 19 | |
| 20 | 2019 | 8 |
About William Cruz‐Muñoz
William Cruz‐Muñoz is a scholar working on Oncology, Cancer Research, Immunology and Allergy, Biotechnology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Nanoplatforms for cancer theranostics (4 papers), Cancer Research and Treatments (4 papers), Cell Adhesion Molecules Research (4 papers), Brain Metastases and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Cancer Research (914 citations), Oncology (1.0k citations), Immunology and Allergy (126 citations), Biotechnology (178 citations) and Hepatology (148 citations). William Cruz‐Muñoz has collaborated with scholars based in Canada, United States and Thailand. Frequent co-authors include Robert S. Kerbel, John M.L. Ebos, Christina R. Lee, Georg Arnold Bjarnason, James G. Christensen, Shan Man, Rama Khokha, Giulio Francia, Ping Xu and Ping Xu. Their work appears in journals such as EMBO Molecular Medicine, Cancer Research, Small, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.